Buy Or Sell Opportunity • May 21
Now 27% undervalued The stock has been flat over the last 90 days, currently trading at CN¥32.57. The fair value is estimated to be CN¥44.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. New Risk • May 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risks High level of debt (55% net debt to equity). Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Reported Earnings • May 01
Full year 2025 earnings released: EPS: CN¥0.08 (vs CN¥0.068 loss in FY 2024) Full year 2025 results: EPS: CN¥0.08 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.2% from FY 2024). Net income: CN¥17.1m (up CN¥31.6m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Anuncio • Apr 30
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China Anuncio • Mar 30
Macmic Science&Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Reported Earnings • Mar 05
Full year 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.068 loss in FY 2024) Full year 2025 results: EPS: CN¥0.082 (up from CN¥0.068 loss in FY 2024). Revenue: CN¥1.35b (up 1.1% from FY 2024). Net income: CN¥17.4m (up CN¥31.9m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Anuncio • Dec 26
Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026 Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026 Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: CN¥0.011 (vs CN¥0.007 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.011 (up from CN¥0.007 in 3Q 2024). Revenue: CN¥302.9m (down 12% from 3Q 2024). Net income: CN¥2.39m (up 56% from 3Q 2024). Profit margin: 0.8% (up from 0.4% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Anuncio • Sep 30
Macmic Science&Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 New Risk • Aug 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change). Anuncio • Jun 30
Macmic Science&Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 New Risk • Jun 05
New major risk - Revenue and earnings growth Earnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years. Reported Earnings • Apr 20
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: CN¥0.068 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.5m (down 113% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 21% per year. Anuncio • Apr 15
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.3% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Anuncio • Mar 28
Macmic Science&Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Reported Earnings • Mar 02
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: CN¥0.066 loss per share (down from CN¥0.55 profit in FY 2023). Revenue: CN¥1.33b (down 12% from FY 2023). Net loss: CN¥14.1m (down 112% from profit in FY 2023). Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 27% per year. Anuncio • Dec 27
Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Anuncio • Dec 06
Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares. Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.11 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.007 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥343.1m (down 7.5% from 3Q 2023). Net income: CN¥1.53m (down 93% from 3Q 2023). Profit margin: 0.4% (down from 6.2% in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥17.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 73% over the past three years. Anuncio • Sep 30
Macmic Science&Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to CN¥14.80, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Semiconductor industry in China. Total loss to shareholders of 70% over the past three years. New Risk • Sep 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin). Reported Earnings • Aug 23
Second quarter 2024 earnings released: EPS: CN¥0.023 (vs CN¥0.15 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.023 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥390.2m (down 9.9% from 2Q 2023). Net income: CN¥4.23m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 7.3% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China. New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (5.9% net profit margin). Anuncio • Jun 28
Macmic Science&Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 23, 2024 Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥24.77, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 60% over the past year. Reported Earnings • Apr 27
First quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.20 profit in 1Q 2023) First quarter 2024 results: CN¥0.01 loss per share (down from CN¥0.20 profit in 1Q 2023). Revenue: CN¥246.4m (down 26% from 1Q 2023). Net loss: CN¥1.72m (down 106% from profit in 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Anuncio • Apr 27
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥24.25, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 69% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥31.47 per share. Buy Or Sell Opportunity • Apr 16
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 34% to CN¥24.25. The fair value is estimated to be CN¥31.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 50% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 115% in 2 years. Earnings are forecast to grow by 204% in the next 2 years. Anuncio • Mar 30
Macmic Science&Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥28.11, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 62% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.05 per share. Anuncio • Mar 01
Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares. Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months. Reported Earnings • Feb 24
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.76 (up from CN¥0.52 in FY 2022). Revenue: CN¥1.51b (up 63% from FY 2022). Net income: CN¥114.8m (up 46% from FY 2022). Profit margin: 7.6% (down from 8.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 8.4%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥28.73, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 25x in the Semiconductor industry in China. Total loss to shareholders of 66% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.10 per share. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥40.84, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 34x in the Semiconductor industry in China. Total loss to shareholders of 53% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.20 per share. Buying Opportunity • Dec 01
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 19%. The fair value is estimated to be CN¥54.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 107% in 2 years. Earnings is forecast to grow by 202% in the next 2 years. New Risk • Nov 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Profit margins are more than 30% lower than last year (7.1% net profit margin). New Risk • Oct 27
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.1% Last year net profit margin: 10% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (7.1% net profit margin). Reported Earnings • Oct 27
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.19 in 3Q 2022). Revenue: CN¥371.0m (up 32% from 3Q 2022). Net income: CN¥23.0m (down 21% from 3Q 2022). Profit margin: 6.2% (down from 10% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China. Price Target Changed • Sep 19
Price target decreased by 10% to CN¥76.50 Down from CN¥85.46, the current price target is an average from 2 analysts. New target price is 47% above last closing price of CN¥52.08. Stock is down 4.4% over the past year. The company is forecast to post earnings per share of CN¥1.04 for next year compared to CN¥0.52 last year. Major Estimate Revision • Aug 24
Consensus EPS estimates increase by 22% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.58b to CN¥1.62b. EPS estimate increased from CN¥0.957 to CN¥1.16 per share. Net income forecast to grow 91% next year vs 68% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥85.85. Share price was steady at CN¥52.06 over the past week. Reported Earnings • Aug 18
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: EPS: CN¥0.21 (up from CN¥0.13 in 2Q 2022). Revenue: CN¥433.3m (up 125% from 2Q 2022). Net income: CN¥31.6m (up 59% from 2Q 2022). Profit margin: 7.3% (down from 10% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China. Anuncio • Jun 28
Macmic Science&Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023 Major Estimate Revision • May 02
Consensus revenue estimates fall by 13% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥1.76b to CN¥1.53b. EPS estimate fell from CN¥1.18 to CN¥1.10 per share. Net income forecast to grow 76% next year vs 61% growth forecast for Semiconductor industry in China. Consensus price target down from CN¥96.50 to CN¥92.50. Share price was steady at CN¥75.08 over the past week. Reported Earnings • Apr 26
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.086 in 1Q 2022). Revenue: CN¥331.2m (up 137% from 1Q 2022). Net income: CN¥30.9m (up 152% from 1Q 2022). Profit margin: 9.3% (up from 8.8% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates by 8.3%. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Major Estimate Revision • Feb 23
Consensus revenue estimates increase by 28% The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from CN¥1.37b to CN¥1.76b. EPS estimate increased from CN¥1.08 to CN¥1.18 per share. Net income forecast to grow 110% next year vs 45% growth forecast for Semiconductor industry in China. Consensus price target broadly unchanged at CN¥97.23. Share price fell 5.8% to CN¥80.90 over the past week. Reported Earnings • Feb 18
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: CN¥0.56. Revenue: CN¥929.2m (up 69% from FY 2021). Net income: CN¥77.2m (up 12% from FY 2021). Profit margin: 8.3% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 25% growth forecast for the Semiconductor industry in China. Price Target Changed • Jan 11
Price target increased to CN¥97.57 Up from CN¥78.35, the current price target is an average from 2 analysts. New target price is 7.5% above last closing price of CN¥90.76. Stock is up 12% over the past year. The company is forecast to post earnings per share of CN¥0.70 for next year compared to CN¥0.60 last year. Reported Earnings • Oct 18
Third quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.072 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.21 (up from CN¥0.072 in 3Q 2021). Revenue: CN¥282.0m (up 108% from 3Q 2021). Net income: CN¥29.0m (up 96% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Semiconductor industry in China. Price Target Changed • Oct 11
Price target decreased to CN¥78.35 Down from CN¥104, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥51.72. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥0.60 last year. Buying Opportunity • Oct 11
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 34%. The fair value is estimated to be CN¥66.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 158% in the next 2 years. Buying Opportunity • Sep 19
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥74.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 38%. Revenue is forecast to grow by 124% in 2 years. Earnings is forecast to grow by 171% in the next 2 years. Reported Earnings • Aug 18
Second quarter 2022 earnings released Second quarter 2022 results: EPS: CN¥0.15. Net income: CN¥20.0m (up CN¥20.0m from 2Q 2021). Over the next year, revenue is forecast to grow 55%, compared to a 48% growth forecast for the Semiconductor industry in China.